Medtronic And Boston Scientific Reach Agreement On Patent Cases

Main Category: Cardiovascular / Cardiology
Article Date: 28 Jan 2009 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:4 stars

4 (1 votes)


Medtronic, Inc. (NYSE: MDT) and Boston Scientific, announced settlements in two cases and an agreement to stand down in three other lawsuits. These agreements stop all current litigation between the two parties in the fields of interventional cardiology and endovascular repair. All the disputes were over intellectual property.

"Stopping this litigation allows us to focus our resources on the development of new products that will improve the quality of care for people with cardiovascular disease," said Scott Ward, president of the CardioVascular business and senior vice president at Medtronic.

The stand down agreements are time limited and are only with Boston Scientific. Medtronic will continue litigation in two of the cases against Abbott Laboratories. While the terms of the settlement remain confidential, Medtronic advised that the above described agreements will not have a material impact on its financial results for its third fiscal quarter. The cases are listed below.

A. Medtronic Vascular, Inc., et al. v. Boston Scientific Corp., et al., No. 2:06-cv-00078-TJW-CMC, pending in the U.S. District Court for the Eastern District of Texas;

B. Boston Scientific Corp., et al. v. Medtronic, Inc., et al., No. 6:08-cv-320, pending in the U.S. District Court for the Eastern District of Texas;

C. Medtronic Vascular, Inc., et al. v. Boston Scientific Corp., et al. and Abbott Laboratories, et al., No. 2:08-cv-00318-TJW, pending in the U.S. District Court for the Eastern District of Texas;

D. Medtronic Vascular, Inc., et al. v. Abbott Cardiovascular Systems, Inc., et al., No. C-06-01066 (PJH), pending in the U.S. District Court for the Northern District of California; and E. Boston Scientific Corp., et al. v. Medtronic, Inc., et al., No. CV 08 3844 PJH, pending in the U.S. District Court for the Northern District of California.

About Medtronic

Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health and extending life for millions of people around the world.

Medtronic, Inc.

Article adapted by Medical News Today from original press release.
Visit our cardiovascular / cardiology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Medtronic, Inc.,. "Medtronic And Boston Scientific Reach Agreement On Patent Cases." Medical News Today. MediLexicon, Intl., 28 Jan. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/137008.php>

APA
Medtronic, Inc.,. (2009, January 28). "Medtronic And Boston Scientific Reach Agreement On Patent Cases." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/137008.php.

Please note: If no author information is provided, the source is cited instead.




Cardiovascular / Cardiology

What Is Heart Rate?

A person's heart rate, also known as their pulse, refers to how many times their heart beats per minute. Our heart rates vary tremendously, depending on the demands we make on our bodies. Read more...

Most Popular Articles



Follow Our Cardiovascular News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cardiovascular / Cardiology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »